The goal of this clinical trial is to analyze the usability and safety of the robotic gait ATLAS 2030 in a cohort of pediatric patients with Spinal Cord Injury, with the aim of extending its indication for use to pediatric spinal cord injury
Having a subacute or chronic spinal cord injury (SCI) and being clinically stable with a general condition good enough to participate in the therapeutic program with the ATLAS 2030.
Age between 3 and 14 years.
Medical authorization to perform standing and gait training with weight-bearing.
Consent from the participant or legal guardian to participate in the study.
Impossibility for the family to complete treatment schedule planning.
Any contraindication for standing and/or walking.
Spasticity (Modified Ashworth Scale (MAS) = 4 in the lower limbs at the time of device use).
Joint contracture of the hip and/or knee > 20 degrees.
MarsiBionics
Lead sponsor
Hospital Nacional de Parapléjicos de Toledo
Collaborator
Fundación del Lesionado Medular
Collaborator